Epidemiology

You have full text access to this OnlineOpen article

Diabetes mellitus and risk of breast cancer: A meta-analysis

  1. Susanna C. Larsson1,†,*,
  2. Christos S. Mantzoros2,
  3. Alicja Wolk1

Article first published online: 30 MAR 2007

DOI: 10.1002/ijc.22717

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 4, pages 856–862, 15 August 2007

Additional Information

How to Cite

Larsson, S. C., Mantzoros, C. S. and Wolk, A. (2007), Diabetes mellitus and risk of breast cancer: A meta-analysis. Int. J. Cancer, 121: 856–862. doi: 10.1002/ijc.22717

Author Information

  1. 1

    Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  2. 2

    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

  1. †

    Fax: +46-8-304571.

*Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE-171 77 Stockholm, Sweden

Publication History

  1. Issue published online: 22 JUN 2007
  2. Article first published online: 30 MAR 2007
  3. Manuscript Accepted: 26 FEB 2007
  4. Manuscript Received: 3 JAN 2007

Funded by

  • The Swedish Cancer Society

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (190K)

References

  • 1
    Wild S,Roglic G,Green A,Sicree R,King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–53.
  • 2
    Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005. Accessed at http://www.cdc.gov/diabetes/pubs/factsheet05.htm on November 1, 2006.
  • 3
    DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004; 88: 787–835, ix.
  • 4
    Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 1996; 7: 605–25.
  • 5
    Kazer RR. Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer 1995; 62: 403–6.
    Direct Link:
  • 6
    Larsson SC,Orsini N,Brismar K,Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006; 49: 2819–23.
  • 7
    Larsson SC,Orsini N,Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679–87.
  • 8
    Huxley R,Ansary-Moghaddam A,Berrington de Gonzalez A,Barzi F,Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076–83.
  • 9
    El-Serag HB,Hampel H,Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369–80.
  • 10
    Wolf I,Sadetzki S,Catane R,Karasik A,Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6: 103–11.
  • 11
    Stroup DF,Berlin JA,Morton SC,Olkin I,Williamson GD,Rennie D,Moher D,Becker BJ,Sipe TA,Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–12.
  • 12
    DerSimonian R,Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
  • 13
    Higgins JP,Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–58.
    Direct Link:
  • 14
    Egger M,Davey Smith G,Schneider M,Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–34.
  • 15
    O'Mara BA,Byers T,Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case–control study. J Chronic Dis 1985; 38: 435–41.
  • 16
    Franceschi S,la Vecchia C,Negri E,Parazzini F,Boyle P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990; 26: 781–5.
  • 17
    La Vecchia C,Negri E,Franceschi S,D'Avanzo B,Boyle P. A case–control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70: 950–3.
  • 18
    Talamini R,Franceschi S,Favero A,Negri E,Parazzini F,La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997; 75: 1699–703.
  • 19
    Weiss HA,Brinton LA,Potischman NA,Brogan D,Coates RJ,Gammon MD,Malone KE,Schoenberg JB. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 1999; 28: 816–23.
  • 20
    Baron JA,Weiderpass E,Newcomb PA,Stampfer M,Titus-Ernstoff L,Egan KM,Greenberg ER. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 2001; 12: 875–80.
  • 21
    de Waard F,Baanders-van Halewijn EA. A prospective study in general practice on breast-cancer risk in postmenopausal women. Int J Cancer 1974; 14: 153–60.
    Direct Link:
  • 22
    Ragozzino M,Melton LJIII,Chu CP,Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982; 35: 13–19.
  • 23
    Adami HO,McLaughlin J,Ekbom A,Berne C,Silverman D,Hacker D,Persson I. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307–14.
  • 24
    Sellers TA,Sprafka JM,Gapstur SM,Rich SS,Potter JD,Ross JA,McGovern PG,Nelson CL,Folsom AR. Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Epidemiology 1994; 5: 102–8.
  • 25
    Steenland K,Nowlin S,Palu S. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995; 4: 807–11.
  • 26
    Goodman MT,Cologne JB,Moriwaki H,Vaeth M,Mabuchi K. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 1997; 26: 144–53.
  • 27
    Weiderpass E,Gridley G,Persson I,Nyren O,Ekbom A,Adami HO. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 1997; 71: 360–3.
    Direct Link:
  • 28
    Hjalgrim H,Frisch M,Ekbom A,Kyvik KO,Melbye M,Green A. Cancer and diabetes—A follow-up study of two population-based cohorts of diabetic patients. J Intern Med 1997; 241: 471–5.
    Direct Link:
  • 29
    Wideroff L,Gridley G,Mellemkjaer L,Chow WH,Linet M,Keehn S,Borch-Johnsen K,Olsen JH. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997; 89: 1360–5.
  • 30
    Mink PJ,Shahar E,Rosamond WD,Alberg AJ,Folsom AR. Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 2002; 156: 349–52.
  • 31
    Michels KB,Solomon CG,Hu FB,Rosner BA,Hankinson SE,Colditz GA,Manson JE. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 2003; 26: 1752–8.
  • 32
    Swerdlow AJ,Laing SP,Qiao Z,Slater SD,Burden AC,Botha JL,Waugh NR,Morris AD,Gatling W,Gale EA,Patterson CC,Keen H. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 2005; 92: 2070–5.
  • 33
    Jee SH,Ohrr H,Sull JW,Yun JE,Ji M,Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194–202.
  • 34
    Khan M,Mori M,Fujino Y,Shibata A,Sakauchi F,Washio M,Tamakoshi A. Site-specific cancer risk due to diabetes mellitus history: evidencefrom the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 2006; 7: 253–9.
  • 35
    Lipscombe LL,Goodwin PJ,Zinman B,McLaughlin JR,Hux JE. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 2006; 98: 349–56.
  • 36
    Inoue M,Iwasaki M,Otani T,Sasazuki S,Noda M,Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871–7.
  • 37
    Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970; 44: 673–86.
  • 38
    Verlato G,Zoppini G,Bonora E,Muggeo M. Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 2003; 26: 1047–51.
  • 39
    Coughlin SS,Calle EE,Teras LR,Petrelli J,Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159: 1160–7.
  • 40
    Zendehdel K,Nyren O,Ostenson CG,Adami HO,Ekbom A,Ye W. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95: 1797–800.
  • 41
    Centers for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999–2000. MMWR Morb Mortal Wkly Rep 2003; 52: 833–7.
  • 42
    Chappell J,Leitner JW,Solomon S,Golovchenko I,Goalstone ML,Draznin B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J Biol Chem 2001; 276: 38023–8.
  • 43
    van der Burg B,Rutteman GR,Blankenstein MA,de Laat SW,van Zoelen EJ. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 1988; 134: 101–8.
    Direct Link:
  • 44
    Papa V,Belfiore A. Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest 1996; 19: 324–33.
  • 45
    Belfiore A,Frittitta L,Costantino A,Frasca F,Pandini G,Sciacca L,Goldfine ID,Vigneri R. Insulin receptors in breast cancer. Ann NY Acad Sci 1996; 784: 173–88.
    Direct Link:
  • 46
    Verheus M,Peeters PH,Rinaldi S,Dossus L,Biessy C,Olsen A,Tjonneland A,Overvad K,Jeppesen M,Clavel-Chapelon F,Tehard B,Nagel G et al. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006; 119: 659–67.
    Direct Link:
  • 47
    Lawlor DA,Smith GD,Ebrahim S. Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 2004; 15: 267–75.
  • 48
    Hirose K,Toyama T,Iwata H,Takezaki T,Hamajima N,Tajima K. Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 2003; 4: 239–46.
  • 49
    Yang G,Lu G,Jin F,Dai Q,Best R,Shu XO,Chen JR,Pan XY,Shrubsole M,Zheng W. Population-based, case–control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 1207–11.
  • 50
    Muti P,Quattrin T,Grant BJ,Krogh V,Micheli A,Schunemann HJ,Ram M,Freudenheim JL,Sieri S,Trevisan M,Berrino F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1361–8.
  • 51
    Toniolo P,Bruning PF,Akhmedkhanov A,Bonfrer JM,Koenig KL,Lukanova A,Shore RE,Zeleniuch-Jacquotte A. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000; 88: 828–32.
    Direct Link:
  • 52
    Kaaks R,Lundin E,Rinaldi S,Manjer J,Biessy C,Soderberg S,Lenner P,Janzon L,Riboli E,Berglund G,Hallmans G. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 2002; 13: 307–16.
  • 53
    Goodwin PJ,Ennis M,Pritchard KI,Trudeau ME,Koo J,Madarnas Y,Hartwick W,Hoffman B,Hood N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002; 20: 42–51.
  • 54
    Wolf I,Sadetzki S,Gluck I,Oberman B,Ben-David M,Papa MZ,Catane R,Kaufman B. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer 2006; 42: 1077–82.
  • 55
    Renehan AG,Harvie M,Howell A. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 2006; 13: 273–8.
  • 56
    Plymate SR,Hoop RC,Jones RE,Matej LA. Regulation of sex hormone-binding globulin production by growth factors. Metabolism 1990; 39: 967–70.
  • 57
    Nestler JE. Insulin regulation of human ovarian androgens. Hum Reprod 1997; 12( Suppl 1): 53–62.
  • 58
    Quinn MA,Ruffe H,Brown JB,Ennis G. Circulating gonadotrophins and urinary oestrogens in postmenopausal diabetic women. Aust N Z J Obstet Gynaecol 1981; 21: 234–6.
    Direct Link:
  • 59
    Nyholm H,Djursing H,Hagen C,Agner T,Bennett P,Svenstrup B. Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab 1989; 69: 946–9.
  • 60
    Kaaks R,Rinaldi S,Key TJ,Berrino F,Peeters PH,Biessy C,Dossus L,Lukanova A,Bingham S,Khaw KT,Allen NE,Bueno-de-Mesquita HB et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005; 12: 1071–82.
  • 61
    Key T,Appleby P,Barnes I,Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 606–16.
  • 62
    Eliassen AH,Missmer SA,Tworoger SS,Spiegelman D,Barbieri RL,Dowsett M,Hankinson SE. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006; 98: 1406–15.
  • 63
    Kaaks R,Berrino F,Key T,Rinaldi S,Dossus L,Biessy C,Secreto G,Amiano P,Bingham S,Boeing H,Bueno de Mesquita HB,Chang-Claude J et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005; 97: 755–65.
View Full Article (HTML) Get PDF (190K)